Tower Research Capital LLC (Trc) Prothena Corp Public LTD CO Transaction History
Tower Research Capital LLC (Trc)
- $3.68 Billion
- Q3 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Prothena Corp Public LTD CO stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 5,457 shares of PRTA stock, worth $78,580. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,457
Previous 6,990
21.93%
Holding current value
$78,580
Previous $144,000
36.81%
% of portfolio
0.0%
Previous 0.0%
Shares
27 transactions
Others Institutions Holding PRTA
# of Institutions
184Shares Held
42.7MCall Options Held
162KPut Options Held
102K-
Eco R1 Capital, LLC San Francisco, CA11.6MShares$167 Million8.41% of portfolio
-
Wellington Management Group LLP Boston, MA4.18MShares$60.2 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.86MShares$55.5 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.82MShares$55 Million0.01% of portfolio
-
Palo Alto Investors LP Palo Alto, CA1.74MShares$25 Million4.0% of portfolio
About PROTHENA CORP PUBLIC LTD CO
- Ticker PRTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,922,800
- Market Cap $676M
- Description
- Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...